NLS Collaboration

The aim of the research collaboration is to reveal the mechanism of action and pharmacological characterization of a drug candidate. Under the terms of the collaboration, Salipro Biotech will utilize its expertise in stabilizing challenging membrane proteins such as GPCRs, ion channels and transporters via its Salipro technology platform to advance a Sumitomo Pharma’s drug […]

This issue includes an exclusive profile interview with Jonina Gudmundsdottir, the CEO of the Icelandic CDMO Coripharma, and a special report on leadership, including advice from leadership expert Pär Skoglund Finquist and Sarah Lidé, the founder of VILDA, a Swedish network for female CEOs in the life science industry. Our hot topics in this issue are […]

Health Data Sweden (HDS) is a European digital innovation hub (EDIH) and the aim is to accelerate the digital maturity in our society and improve the use of health data. The free services delivered through HDS are aimed at small and medium-sized companies (SMEs) as well as the public sector in Sweden and Europe. A […]

Valo Therapeutics has announced a collaboration with global contract research organization, Texcell, to investigate immune responses to PeptiCRAd-1 in its Phase 1 clinical study. ValoTx’s PeptiCRAd-1 combines the power of a tumor-specific adenovirus (expressing immune-stimulatory molecules CD40L and OX40L) with immunogenic tumor peptides derived from NY-ESO-1 and MAGE-A3 proteins thereby generating tumor-specific, cytotoxic T-cells that […]

Mendus has entered into a manufacturing alliance with NorthX Biologics and has announced a directed share issue and a fully secured rights issue of units totaling approximately 317 million SEK in financing. In the alliance with NorthX, Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which will be used for late-stage development […]

Qlucore has presented the first results from an EU-funded project for improved diagnosis of lung cancer. The presented results, a new classification model, not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer. This information can have significant implications […]